Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,126 | 85,820 | 36,088 | 54,539 | 73,933 |
| Marketable Securities | 29,690 | N/A | 113,895 | 138,704 | 131,149 |
| Receivables | 1,785 | N/A | N/A | N/A | N/A |
| TOTAL | $100,189 | $92,665 | $155,078 | $198,369 | $207,610 |
| Non-Current Assets | |||||
| PPE Net | 19,495 | 26,294 | 32,931 | 36,125 | 7,751 |
| Investments And Advances | 1,400 | 1,400 | 1,400 | 36,752 | 0 |
| Other Non-Current Assets | 11,356 | 113 | 113 | 1,400 | 1,539 |
| TOTAL | $32,251 | $27,807 | $34,444 | $74,277 | $9,290 |
| Total Assets | $132,440 | $120,472 | $189,522 | $272,646 | $216,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,859 | 6,415 | 7,033 | 7,587 | 5,397 |
| Accrued Expenses | 10,884 | 15,207 | 12,513 | 10,812 | 5,523 |
| TOTAL | $45,993 | $42,041 | $31,625 | $30,457 | $10,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,648 | N/A | 8,989 | 10,730 | 586 |
| Deferred Revenues | 25,794 | 20,419 | 12,079 | 12,058 | N/A |
| Other Non-Current Liabilities | 16,178 | 644 | 1,129 | 0 | 0 |
| TOTAL | $134,771 | $126,476 | $97,198 | $109,558 | $586 |
| Total Liabilities | $180,764 | $168,517 | $128,823 | $140,015 | $11,506 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,554 | 2,052 | 2,032 | 2,018 | 1,959 |
| Common Shares | 70 | 41 | 40 | 40 | 39 |
| Retained earnings | -459,649 | -389,370 | -263,571 | -174,191 | -82,612 |
| Other shareholders' equity | 0 | 0 | -146 | -149 | 30 |
| TOTAL | $-48,324 | $-48,045 | $60,699 | $132,631 | $205,394 |
| Total Liabilities And Equity | $132,440 | $120,472 | $189,522 | $272,646 | $216,900 |